|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0229 USD | -4.58% |
|
+1.78% | -62.70% |
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-14 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.9M 4.29M 3.96M 3.7M 6.96M 463M 7.11M 47.62M 18.38M 228M 18.38M 17.98M 793M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.61M 5.79M 5.35M 4.99M 9.4M 625M 9.61M 64.33M 24.83M 308M 24.84M 24.29M 1.07B | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | -4.58% | ||
| 1 week | +1.78% | ||
| Current month | -16.42% | ||
| 1 month | -16.42% | ||
| 3 months | -26.13% | ||
| 6 months | -54.65% | ||
| Current year | -62.70% |
| 1 week | 0.02 | 0.03 | |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.4 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-17 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 25-02-17 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 25-02-17 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.58% | +1.78% | -38.11% | -46.62% | 4.9M | ||
| +1.34% | +10.63% | +56.40% | +162.48% | 1,077B | ||
| +0.82% | +10.82% | +67.81% | +56.20% | 613B | ||
| +0.64% | +10.47% | +36.89% | +90.72% | 448B | ||
| +1.86% | +4.85% | +28.17% | +22.04% | 332B | ||
| -0.14% | +7.58% | +41.28% | +27.25% | 293B | ||
| -0.06% | +4.92% | +31.23% | +41.59% | 286B | ||
| -0.96% | +4.98% | -28.37% | -40.96% | 215B | ||
| +0.54% | +4.38% | +28.87% | +62.70% | 193B | ||
| -1.49% | +0.82% | +13.56% | +65.64% | 159B | ||
| Average | -0.19% | +9.63% | +23.77% | +44.10% | 361.61B | |
| Weighted average by Cap. | +0.69% | +9.65% | +41.72% | +80.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.75M 12.69M 11.85M 22.32M 1.48B 22.82M 153M 58.98M 733M 58.98M 57.68M 2.54B | 13.79M 12.07M 11.15M 10.41M 19.59M 1.3B 20.04M 134M 51.78M 643M 51.78M 50.65M 2.23B |
| Net income | -2.39M -2.1M -1.94M -1.81M -3.4M -226M -3.48M -23.29M -8.99M -112M -8.99M -8.79M -388M | -958K -839K -774K -723K -1.36M -90.57M -1.39M -9.32M -3.6M -44.68M -3.6M -3.52M -155M |
| Net Debt | 325K 285K 263K 245K 462K 30.73M 472K 3.16M 1.22M 15.16M 1.22M 1.19M 52.63M | 1.72M 1.5M 1.39M 1.3M 2.44M 162M 2.5M 16.71M 6.45M 80.13M 6.45M 6.31M 278M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | US$0.0229 | -4.58% | 314,088 |
| 26-06-26 | US$0.0240 | +9.09% | 1,840,006 |
| 26-06-25 | US$0.0220 | 0.00% | 1,634,141 |
| 26-06-24 | US$0.0220 | +5.90% | 336,634 |
| 26-06-23 | US$0.0208 | -7.67% | 862,510 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions

















